Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fed’s Mester Says I Think Will Need To Take Rates Above 4% And Leave Them There

-Reuters

byBenzinga Newsdesk

August 26, 2022

1 minute read

-Reuters

Atar Biotherapeutics Reports European Medicines Agency Grant For Co.’s Accelerated Assessment Of tab-cel For Treatment Of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

By Benzinga Newsdesk

September 27, 8:35 AM

Designation recognizes therapeutic innovation and potential to address significant unmet patient need Atara on track to submit MAA in November 2021 Phase 3 ALLELE study analysis supporting tab-cel MAA to be presented

ATRA

MoffettNathanson Initiates Coverage On HashiCorp with Outperform Rating, Announces Price Target of $43

By Benzinga Newsdesk

February 13, 7:55 AM

MoffettNathanson analyst Sterling Auty initiates coverage on HashiCorp (NASDAQ:HCP) with a Outperform rating and announces Price Target of $43.

HCP

Why Zillow Shares Are Trading Higher Today

By Adam Eckert

February 11, 10:08 AM

Zillow Group Inc (NASDAQ: Z) (NASDAQ: ZG) is trading higher Friday morning after the company announced strong fourth-quarter financial results.

Piper Sandler Downgrades RingCentral to Neutral, Announces $39 Price Target

By Benzinga Newsdesk

January 17, 6:20 AM

Piper Sandler analyst James Fish downgrades RingCentral (NYSE:RNG) from Overweight to Neutral and announces $39 price target.

RNG

Fed’s Mester Says I Think Will Need To Take Rates Above 4% And Leave Them There

Related Posts

Atar Biotherapeutics Reports European Medicines Agency Grant For Co.’s Accelerated Assessment Of tab-cel For Treatment Of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

MoffettNathanson Initiates Coverage On HashiCorp with Outperform Rating, Announces Price Target of $43

Why Zillow Shares Are Trading Higher Today

Piper Sandler Downgrades RingCentral to Neutral, Announces $39 Price Target